Location Pfizer
Michael Ku is senior vice president and head of Global Clinical Supply at Pfizer’s Research and Development organization. He has more than 30 years of biopharmaceutical experience and provides strategic leadership for clinical supply chain functions supporting Pfizer’s clinical trials in more than 70 countries. His intellectual curiosity and focus on technology and innovation drive his passion for leading the global clinical supply chain to deliver breakthrough medicines and vaccines that change patients’ lives.
Before joining Pfizer, Ku was global vice president and head of Clinical Pharmacy Research Services at Genzyme Corp. He also held roles of increasing responsibility at Astra Pharmaceuticals (now AstraZeneca) and Novopharm Ltd. (now Teva Canada Ltd.) in clinical research, pharmacovigilance, regulatory affairs and quality assurance.
At Pfizer, Ku serves as an executive sponsor for the Pfizer Pharmacy Association and founded the Pfizer/MCPHS Biopharmaceutical Fellowship Program as program director and adjunct assistant professor of pharmacy practice at MCPHS University.
Ku earned a Doctor of Pharmacy and a Bachelor of Science in pharmacy from MCPHS University, as well as a Master of Business Administration from Anna Maria College. He also holds a Bachelor of Science in toxicology from the University of Toronto and is a graduate of the Advanced Management Program and General Management Program at Harvard Business School.